cdk4/6i in hr sabcs 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. sara tolaney
Published 1 year ago • 223 plays • Length 14:40Download video MP4
Download video MP3
Similar videos
-
15:24
breast cancer asco 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. sara tolaney
-
17:19
hr sabcs 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. stephanie graff
-
16:56
tnbc sabcs 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. maryam lustberg
-
14:52
her2 sabcs 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. erika hamilton
-
20:03
destiny-breast04 study discussion - oncbrothers (rohit and rahul gosain) with dr. shanu modi
-
6:24
cdk4/6 inhibitors: can they be used for tnbc or her2 breast cancer?
-
6:16
cyclins and cdks cell cycle regulation
-
7:13
the biological rationale for cdk4/6 inhibitors
-
52:18
webinar on management of mbc - cdk4/6 inhibitors
-
56:01
dr. rinath jeselsohn | demystifying cdks in breast cancer beyond cdk46 | sabcs 2022
-
52:13
highlights from sabcs 2020: new data on cdk4/6 inhibitors, omitting chemotherapy and radiotherapy
-
3:24
cdk4/6 for hr early breast cancer: monarche results
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
26:34
cdk 4/6 inhibitors in breast cancer advanced and adjuvant settings
-
1:18
esmo22: breast cancer research by sara tolaney, md (tropics) | dana-farber cancer institute
-
1:37
dr. han on the differences between cdk 4/6 inhibitors in er breast cancer
-
27:19
upper gastrointestinal cancer | 2022 oneoncology conference
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen
-
2:31
cdk4/6 inhibitors: a hot topic in breast cancer treatment
-
4:48
sabcs 2016 - sara tolaney
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer